Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2026-01-01 @ 11:07 AM
Study NCT ID:
NCT05413369
Status:
COMPLETED
Last Update Posted:
2025-09-24
First Post:
2022-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LPS17396
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None